We focus on FDA-approved GLP-1 care pathways.
Is Mounjaro a controlled substance?
This sits in the medication access step when checking prescription and pharmacy requirements.
Mounjaro is not listed as a controlled substance in the federal schedules published by the U.S. Drug Enforcement Administration. Its active ingredient is tirzepatide.
Mounjaro is still a prescription medication. Lilly identifies Mounjaro as available by prescription only in its official product information.
Not being a controlled substance does not determine whether a plan will cover Mounjaro, require prior authorization, or apply other pharmacy restrictions. Those rules are set by the health plan and can vary.